Literature DB >> 7543388

Mesangiolysis associated with severe glomerular endocapillary proliferation of CD57 large granular lymphocytes.

O Hotta1, S Miyazawa, Y Taguma, S Onodera, H Kitamura, N Yusa, K Nakamura.   

Abstract

A 54-year-old man developed renal failure, with renal biopsy findings of diffuse mesangiolysis with severe endocapillary proliferation. Immunohistochemical studies revealed that CD3-CD56-CD57+ large granular lymphocytes were present predominantly within glomerular tufts. Intercellular adhesion molecule-1 was more preferentially expressed in the glomerular endothelial cells with severe endocapillary proliferation as compared to those without endocapillary proliferation. These findings suggest that CD57+ large granular lymphocytes caused glomerular endothelial injury by a cell-mediated cytolytic mechanism, resulting in the development of mesangiolysis and microaneurysm formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543388

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Mice with early onset of death (EOD) due to lupus glomerulonephritis.

Authors:  S Honda; K Nemoto; T Mae; K Kinjoh; M Kyogoku; H Kawamura; S Miyazawa; A Weerashinghe; H Watanabe; J Narita; T Koya; M Arakawa; T Abo
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  A case of endocapillary glomerulonephritis associated with peripheral blood natural killer cell proliferation.

Authors:  Tomoya Kishi; Yuji Ikeda; Motoaki Miyazono; Noriyasu Fukushima; Shigehisa Aoki; Toru Sanai; Takanobu Sakemi
Journal:  NDT Plus       Date:  2011-07-27

3.  Spectrum of Kidney Disorders Associated with T-Cell Immunoclones.

Authors:  Alexis Piedrafita; François Vergez; Julie Belliere; Nais Prades; Magali Colombat; Antoine Huart; Jean-Baptiste Rieu; Stéphanie Lagarde; Arnaud Del Bello; Nassim Kamar; Dominique Chauveau; Camille Laurent; Lucie Oberic; Loïc Ysebaert; David Ribes; Stanislas Faguer
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.